The Year in Commercial Real Estate

From a booming life science industry spreading further out from East Cambridge to new multifamily housing models and an e-commerce-fueled explosion in interest in distribution facilities, here’s what drove demand in 2019.

Office and Lab Pipeline Hits Cyclical High

Due to the scarcity of developable sites in key urban markets, both office and lab developers are getting more creative and increasingly pursuing opportunities outside of traditional business districts, like the South End, South Boston, Somerville and Allston-Brighton.

South Boston Lab Site Could Sell for $80M

Developers that bought a South Boston warehouse property for $25 million just over a year ago are preparing to cash out after gaining approval for an office-lab complex on the primed-for-life science A Street corridor.

Building Ahead of the Market

Building lab-ready buildings on speculation has been a no-lose development proposition in recent years, spilling out of the life science industry’s Cambridge hub to an ever-expanding list of relief valve markets from Boston’s Seaport District to Metrowest.

Life Science in the Driver’s Seat

The development boom in Greater Boston showed staying power in 2017 as the region continued to attract commitments from major office and lab tenants. Big leases by Alexion Pharmaceuticals, PTC and Rapid7 reflected the appeal of brand-new office towers in the Seaport and North Station neighborhoods, while life science companies looked beyond Kendall Square for growth. Class A office and lab markets continued to grow in inner suburbs such as Somerville and Watertown, driven by the expanding life science industry. Apartment and condominium developers increasingly focused on outlying Boston neighborhoods and transit-friendly suburban neighborhoods.